Oncologic Biologic Biosimilars Are Coming to Market: Are You Ready?
Biosimilars have proven themselves to the U.S. FDA, but clinicians are still wary. By Leah K. Lawrence Posted: June 2018 Healthcare providers are more than familiar with the use of […] Read more
By Tiziana Vavalà, MD, andSilvia Novello, MD, PhD Posted: April 2018 Approximately 1.8 million new lung cancer cases worldwide are diagnosed annually, and 85% of these cases are NSCLC. Only […] Read more
By Annemie Snoeckx, MD, andPaul E. Van Schil, MD, PhD Posted: April 2018 No universally accepted guidelines or management protocols exist for diagnosis and treatment of screen-detected nodules. Radiologic management […] Read more
Availability of next-generation sequencing continues to improve, but current technology cannot speed turnaround time of results. Posted: February 2018 The standard of care for all patients diagnosed with advanced nonsquamous […] Read more
IASLC 18th WCLC Special Session Provides Overview of Updated Guidelines for Molecular Testing
Posted: December 2017 Experts in molecular testing discussed various issues on this topic in October at the IASLC 18th WCLC. Neal Lindeman, MD, led off the session with an overview […] Read more
By Christian Rolfo, MD, PhD, MBAh, and Philip C. Mack, PhD Posted: December 2017 In just the past decade, tremendous advancements in the treatment of metastatic non-small cell lung cancer […] Read more
Evolution in Treatment of Brain Metastases in Mutation-Driven Non-Small Cell Lung Cancer
By Jason K. Molitoris, MD, PhD, Anthony D. Nehlsen, MD, and Minesh P. Mehta, MD Posted: October 2017 Up to 40% of patients with advanced non-small cell lung cancer (NSCLC) […] Read more
Mental Health Really Matters: Lung Cancer Diagnosis Has the Greatest Risk of Suicide among Cancer Patients in USA – SEER Database Analysis
By Mohamed Rahouma, MD, Mohamed Kamel, MD, and Jeffrey L. Port, MD A cancer diagnosis can be overwhelming, especially if someone has limited social support. Previous international reports have indicated […] Read more
Posted: June 2017 Despite very encouraging progress in the development and use of immunotherapy for patients with non-small cell lung cancer, much confusion remains regarding patient selection for each therapy. […] Read more
Posted: June 2017 For the past 40 years the International Association for the Study of Lung Cancer has remained the only society exclusively dedicated to the study and treatment of […] Read more